Human recombinant interleukin-2 augments blastogenesis of bovine and porcine lymphocytes
- 1 September 1986
- journal article
- research article
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 13 (1-2) , 31-38
- https://doi.org/10.1016/0165-2427(86)90046-2
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Response of resting human peripheral blood natural killer cells to interleukin 2.The Journal of Experimental Medicine, 1984
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984
- Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coliScience, 1984
- Interleukin 2 enhances natural killing of normal lymphocytesCellular Immunology, 1984
- In vitro growth of cytotoxic human lymphocytesCellular Immunology, 1982
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.The Journal of Experimental Medicine, 1982
- Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.The Journal of Experimental Medicine, 1980
- T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu miceNature, 1980
- Selective in Vitro Growth of T Lymphocytes from Normal Human Bone MarrowsScience, 1976